Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- FEIM +29.9%, AENT +28.9%, RH +6.8%, ORCL +5.7%, CPRT +5.3% (also to acquire ACVA for $10.50/share in cash), DSGX +3.3%, REF +1%
Other news:
- ACVA +44.2% (to be acquired by CPRT for $10.50/sh)
- THO +10% (further leadership changes as part of previously announced evolution of its North American RV operating model)
- ATEC +6.8% (CEO disclosed the purchase of 115,000 shares at $8.73 - $8.84 worth approximately $1.0 mln (transaction date 9/10))
- XP +3.9% (stock offering by selling shareholder)
- GME +3.8% (President, CEO and Chairman Ryan Cohen bought 1 mln shares of Class A Common Stock at $20.0199 - $20.4699 worth about $20.4 mln (transaction date 9/10))
- SI +3% (gets FDA 510(k) clearance for N-22 Humeral Head, starts full launch)
- UNTY +2.7% (expects one-time Q3 tax benefit)
- CELH +2.5% (CEO bought 18000 shares worth ~$494K)
- CATX +2.2% (receives acceptance of VMT-a-NET Data for presentation at the 38th EORTC-NCI-AACR Symposium 2026)
- VIK +1.8% (authorizes new $1 bln share repurchase program)
- FBRT +1.8% (authorizes new $50 mln share repurchase program)
- CRDL +1.5% (files preliminary $150 mln base shelf prospectus)
- BBWI +1.5% (activist Barington Capital takes stake, according to Bloomberg)
- NRXP +1.5% (announces that its subsidiary, HOPE Therapeutics, will be the first Interventional Psychiatry to deploy Zeta Surgical's newly FDA-cleared Zeta TMS Robotic System, with clinical staff now in training ahead of deployment in Florida)
- RKLB +1.4% (completes 16th Electron launch of 2026, deploys Earth observation satellite)
- MTN +1.3% (provides update following close of nominations window, reiterates active search underway in its ongoing commitment to Board refreshment)
- VFS +1.3% (announced preliminary August domestic Vietnam deliveries of 20,161 EVs, representing an increase of 12% compared to the previous month)
- BGSI +1.3% (launches buyback for up to 10% of public float through normal course bid)